ACADIA Pharmaceuticals Inc —— 现金流量表 (NASDAQ:ACAD) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -136.17 M-125.66 M-114.03 M16.7 M157.72 M109.84 M 109.84 M 投资活动产生的现金 192.51 M-71.1 M73.24 M32 M-30.54 M-302.56 M -302.56 M 融资活动产生的现金 81 M18.16 M8.2 M25.13 M6.84 M49.88 M 49.88 M 自由现金流 -143.75 M-126.78 M-114.03 M-23.35 M157.2 M6.31 M 6.61 M

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

新闻

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

JAZZ or ACAD: Which Is the Better Value Stock Right Now?

Acadia Pharmaceuticals任命Jonathan M. Poole为董事会成员

Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

美国银行因欧盟挫折下调Acadia Pharmaceuticals目标价